Medical Condition News

RSS

Study challenges concerns linking ADHD medication to self-harm risk

The risk of self-harm amongst people with attention deficit hyperactivity disorder (ADHD) is highest before people start ADHD medication, rather than after treatment begins, according to new research led by Aston University.

22 Oct 2026

Are heavy school bags really to blame for children's back pain?

A study of 221 schoolchildren in the Czech Republic found no statistically significant association between relative school bag weight and back pain, although nearly half reported experiencing back discomfort in the previous month. Longer carrying duration was weakly associated with perceived heaviness, suggesting that bag weight and carrying time capture different aspects of children's experiences.

22 Oct 2026

A study of 802 teens raises questions about school breakfast and blood sugar

A study of 802 U.S. adolescents found that school breakfast participation at least once weekly was associated with a 30% higher prevalence of prediabetes-range glucose markers, while school lunch participation showed no significant association. Higher intakes of vitamins E and B6 and fruit consumption among adolescents with obesity were associated with lower prediabetes prevalence, but none of the reported associations remained statistically significant after correction for multiple comparisons.

22 Oct 2026

Unstable immune cells linked to severe cancer immunotherapy side effects

Scientists at the University of Pittsburgh uncovered the unstable immune cells that can cause up to 40% of immunotherapy patients to experience serious side effects and showed that diet and microbiome composition influence the side effect's severity.

22 Oct 2026

Starting survivorship care earlier improves head and neck cancer survival

Beginning survivorship care for head and neck cancer patients earlier is linked to better survival and lower recurrence, according to a new University of Pittsburgh study published today in JAMA Otolaryngology–Head & Neck Surgery.

22 Oct 2026

FDA grants accelerated approval to groundbreaking rectal cancer immunotherapy

A groundbreaking immunotherapy treatment for rectal cancer, developed through pioneering research at Memorial Sloan Kettering Cancer Center (MSK) with critical early-stage funding from Swim Across America, has received accelerated approval from the U.S. Food and Drug Administration (FDA).

22 Oct 2026

ESMO updates precision oncology framework to improve targeted therapies

ESMO has published version 2 of the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT), a major update to the internationally recognized precision oncology framework that helps oncologists assess the clinical relevance of molecular alterations and match patients with the most appropriate targeted therapies.

22 Oct 2026

ESMO introduces new set of principles to strengthen the communication of cancer research

The new 'ESMO Principles for Humanising Scientific Reporting' aim to strengthen the communication of oncology research, connect scientific evidence with patient relevance, and support a more patient-centered approach to cancer research communication.

22 Oct 2026

Intermittent fasting combined with exercise promotes weight loss in obese adults

A trial led by the Joint University Institute for Sport and Health shows benefits regarding weight, body fat, and cardiorespiratory fitness in people with obesity.

22 Oct 2026

Obesity impairs key immune cells but bariatric surgery reverses damage

New Maynooth University (MU) research led by the Department of Biology's Dr Ciara Flynn, working within the research group of Prof Andrew Hogan at the Kathleen Lonsdale Institute for Human Health Research has found that obesity can impair key immune cells that help protect the body against infection and cancer.

22 Oct 2026

AGA/AASLD joint guideline evaluates newer medications for primary biliary cholangitis

For the first time, a joint guideline from the American Gastroenterological Association (AGA) and American Association for the Study of Liver Diseases (AASLD) evaluates newer medications for primary biliary cholangitis (PBC), the most common cholestatic disease in adults.

22 Oct 2026

Young cancer survivors face critical gaps in follow-up care

Young adult cancer survivors face gaps in follow-up care caused by factors including geographic mobility and insurance changes, according to an analysis by UTHealth Houston researchers.

22 Oct 2026

Half-matched bone marrow transplants show high survival in young aplastic anemia patients

Researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins Children's Center report that bone marrow transplant using half-matched family donors achieved a 96% survival rate among children, adolescent, and young adult patients with severe aplastic anemia, a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells.

22 Oct 2026

Community health workers help patients piece their lives back together

For Georgieanna Pierre-Paul-who wants everyone to call her Gee-the most important part of her job may be a comfortable pair of shoes.

22 Oct 2026

Artificial intelligence in stroke rehabilitation: A structured clinical review

Stroke is a major cause of long-term disability, and recovery varies substantially across motor, cognitive, communication, and activities-of-daily-living domains, making continuous assessment and individualized rehabilitation essential.

22 Oct 2026

Are shared fryers really off-limits for people with celiac disease?

A study finds most French fries and tortilla chips from shared fryers contain low gluten levels, suggesting revised dietary advice for celiac disease is needed.

22 Oct 2026

Depression profile linked to disrupted sleep and poorer treatment responses

This study uncovers a circadian depression subtype, revealing links between sleep patterns, symptom severity, and antidepressant response in a large cohort.

22 Oct 2026

New study explores psychedelic therapy for co-occurring cocaine addiction and depression

A team of UTHealth Houston researchers has been awarded a five-year, $3.4 million grant to study whether psilocybin-assisted therapy is a viable treatment option for individuals with co-occurring cocaine use disorder and major depressive disorder.

22 Oct 2026

New national trial platform aims to accelerate Alzheimer's disease prevention

Researchers from the University of California San Diego will join a collaboration as part of a federal award of up to $41 million to launch a national effort aimed at accelerating the search for treatments that could prevent or slow Alzheimer's disease.

22 Oct 2026

Stem cell therapies may need new protein quality control standards

Current Good Manufacturing Practice (GMP) standards for cell therapies assess identity, viability, sterility, and genetic stability. For extracellular vesicle (EV) products, Minimal Information for Studies of Extracellular Vesicles (MISEV2023) guidance adds particle size, concentration, markers, morphology, contaminants, endotoxin, and assays.

22 Oct 2026